Strides acquires Sandoz
Strides agreed to acquire Sandoz. Reported deal value: $12M. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Basel, Basel-City, Switzerland.
This page summarizes publicly available information about the transaction as of 2026-03-18. Figures and status may change as filings and press coverage update.
Strides Pharma Subsidiary Acquires Generic Pharma ceutical Brands from Sandoz to Expand African Market Presence by GOAI Share To Strides Pharma Science has announced that its subsidiary, Strides Pharma International AG , has finalized agreements to acquire multiple generic pharmaceutical brands from Sandoz AG , Switzerland , and its affiliated entities
Deal timeline
This transaction is classified in Pharmaceuticals with a reported deal value of $12M. Figures and status may change as sources update.